178 related articles for article (PubMed ID: 25252660)
21. Epigenetics, autism spectrum, and neurodevelopmental disorders.
Rangasamy S; D'Mello SR; Narayanan V
Neurotherapeutics; 2013 Oct; 10(4):742-56. PubMed ID: 24104594
[TBL] [Abstract][Full Text] [Related]
22. Incorporating "motivation" into the functional analysis of challenging behavior: on the interactive and integrative potential of the motivating operation.
Langthorne P; McGill P; O'Reilly M
Behav Modif; 2007 Jul; 31(4):466-87. PubMed ID: 17548541
[TBL] [Abstract][Full Text] [Related]
23. The Way Forward for Mechanism-Based Therapeutics in Genetically Defined Neurodevelopmental Disorders.
Modi ME; Sahin M
Clin Pharmacol Ther; 2018 Oct; 104(4):603-606. PubMed ID: 30101418
[TBL] [Abstract][Full Text] [Related]
24. Pathways to drug development for autism spectrum disorders.
Hampson DR; Gholizadeh S; Pacey LK
Clin Pharmacol Ther; 2012 Feb; 91(2):189-200. PubMed ID: 22205199
[TBL] [Abstract][Full Text] [Related]
25. Autism spectrum disorders and epigenetics.
Grafodatskaya D; Chung B; Szatmari P; Weksberg R
J Am Acad Child Adolesc Psychiatry; 2010 Aug; 49(8):794-809. PubMed ID: 20643313
[TBL] [Abstract][Full Text] [Related]
26. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.
Etkin A; Wager TD
Am J Psychiatry; 2007 Oct; 164(10):1476-88. PubMed ID: 17898336
[TBL] [Abstract][Full Text] [Related]
27. Fear of the unknown: uncertain anticipation reveals amygdala alterations in childhood anxiety disorders.
Williams LE; Oler JA; Fox AS; McFarlin DR; Rogers GM; Jesson MA; Davidson RJ; Pine DS; Kalin NH
Neuropsychopharmacology; 2015 May; 40(6):1428-35. PubMed ID: 25502633
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of developmental disorders.
Brodsky M; Lombroso PJ
Dev Psychopathol; 1998; 10(1):1-20. PubMed ID: 9524805
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic approaches in autism spectrum disorders].
Ruggieri VL; Arberas CL
Rev Neurol; 2015 Feb; 60 Suppl 1():S45-9. PubMed ID: 25726823
[TBL] [Abstract][Full Text] [Related]
30. The amygdala, autism and anxiety.
Amaral DG; Corbett BA
Novartis Found Symp; 2003; 251():177-87; discussion 187-97, 281-97. PubMed ID: 14521193
[TBL] [Abstract][Full Text] [Related]
31. Amygdala regulation of fear and emotionality in fragile X syndrome.
Olmos-Serrano JL; Corbin JG
Dev Neurosci; 2011; 33(5):365-78. PubMed ID: 21893939
[TBL] [Abstract][Full Text] [Related]
32. [Anorexia nervosa in the light of neurocognitive functioning: New theoretical and therapeutic perspectives].
Martinez G; Cook-Darzens S; Chaste P; Mouren MC; Doyen C
Encephale; 2014 Apr; 40(2):160-7. PubMed ID: 23541918
[TBL] [Abstract][Full Text] [Related]
33. Behavioral phenotypes in genetic syndromes: genetic clues to human behavior.
Cassidy SB; Morris CA
Adv Pediatr; 2002; 49():59-86. PubMed ID: 12214780
[TBL] [Abstract][Full Text] [Related]
34. The Prader-Willi phenotype of fragile X syndrome.
Nowicki ST; Tassone F; Ono MY; Ferranti J; Croquette MF; Goodlin-Jones B; Hagerman RJ
J Dev Behav Pediatr; 2007 Apr; 28(2):133-8. PubMed ID: 17435464
[TBL] [Abstract][Full Text] [Related]
35. Amygdaloid regional cerebral blood flow and subjective fear during symptom provocation in anxiety disorders.
Fredrikson M; Furmark T
Ann N Y Acad Sci; 2003 Apr; 985():341-7. PubMed ID: 12724169
[TBL] [Abstract][Full Text] [Related]
36. [Molecular advances in "non-mendelian" genetics. Implications for pediatrics].
Pérez Jurado LA
An Esp Pediatr; 1993 Jun; 38(6):479-87. PubMed ID: 8368674
[No Abstract] [Full Text] [Related]
37. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
[TBL] [Abstract][Full Text] [Related]
38. [Functional neuroimaging of the amygdala: the response to threatening and phobogenic stimuli].
Del Casale A; Ferracuti S; Rapinesi C; Serata D; Simonetti A; Caloro M; Caltagirone SS; Brugnoli C; Kotzalidis GD; Tatarelli R; Girardi P
Riv Psichiatr; 2013; 48(1):35-42. PubMed ID: 23438699
[TBL] [Abstract][Full Text] [Related]
39. From genes to brain development to phenotypic behavior: "dorsal-stream vulnerability" in relation to spatial cognition, attention, and planning of actions in Williams syndrome (WS) and other developmental disorders.
Atkinson J; Braddick O
Prog Brain Res; 2011; 189():261-83. PubMed ID: 21489394
[TBL] [Abstract][Full Text] [Related]
40. The pathophysiology, medical management and dental implications of fragile X, Rett, and Prader-Willi syndromes.
Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
J Calif Dent Assoc; 2003 Sep; 31(9):693-702. PubMed ID: 14560873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
